ATE409458T1 - Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen - Google Patents

Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen

Info

Publication number
ATE409458T1
ATE409458T1 AT02721011T AT02721011T ATE409458T1 AT E409458 T1 ATE409458 T1 AT E409458T1 AT 02721011 T AT02721011 T AT 02721011T AT 02721011 T AT02721011 T AT 02721011T AT E409458 T1 ATE409458 T1 AT E409458T1
Authority
AT
Austria
Prior art keywords
treatment
prevention
mucous
affections
dosage forms
Prior art date
Application number
AT02721011T
Other languages
English (en)
Inventor
Jeremy Jacob
David Nowotnik
Christiane Baud
Original Assignee
Access Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Access Pharma Inc filed Critical Access Pharma Inc
Application granted granted Critical
Publication of ATE409458T1 publication Critical patent/ATE409458T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02721011T 2001-02-15 2002-02-15 Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen ATE409458T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26904901P 2001-02-15 2001-02-15

Publications (1)

Publication Number Publication Date
ATE409458T1 true ATE409458T1 (de) 2008-10-15

Family

ID=23025584

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02721011T ATE409458T1 (de) 2001-02-15 2002-02-15 Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen

Country Status (11)

Country Link
US (1) US7547433B2 (de)
EP (2) EP1997478B1 (de)
AT (1) ATE409458T1 (de)
CA (1) CA2441352C (de)
CY (1) CY1108678T1 (de)
DE (1) DE60229109D1 (de)
DK (2) DK1363600T3 (de)
ES (2) ES2314049T3 (de)
NZ (1) NZ549469A (de)
PT (2) PT1997478E (de)
WO (1) WO2002064113A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1609468A3 (de) * 2000-11-22 2006-01-25 Rxkinetix, Inc. Eine Zusammensetzung auf der Basis eines Schwefel enthaltenden Antioxidans wie dessen Verwendung zur Herstellung eines Medikaments für die Behandlung von Mucositis
GB0126064D0 (en) * 2001-10-30 2001-12-19 Reckitt Benckiser Healthcare Improvements in or relating to organic compositions
US7132111B2 (en) * 2003-01-03 2006-11-07 Epien Medical, Inc. Odorless formulation for treating mucosal discontinuities
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
JP2007522077A (ja) * 2003-08-21 2007-08-09 アクセス ファーマシューティカルズ， インコーポレイテッド 粘膜の疾患および障害の予防および処置のための液体製剤
DE10356248A1 (de) * 2003-11-13 2005-06-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
ES2344911T3 (es) 2004-08-02 2010-09-09 Glaxo Group Limited Composicion novedosa para tratar la xerostomia.
BRPI0608154A2 (pt) * 2005-02-16 2016-10-11 Wyeth Corp métodos de tratar ou inibir mucosite, cistite por radiação em um indivíduo, e de tratar pelo menos um sintoma de exposição de um indivíduo a um agente citotóxico ou à radiação, e, composição farmacêutica
PL1890732T3 (pl) 2005-06-17 2018-11-30 Wisconsin Alumni Research Foundation Preparaty zwężające naczynia krwionośne do podawania miejscowego i sposoby ochrony komórek podczas chemioterapii i radioterapii przeciwnowotworowej
AU2016202290B2 (en) * 2005-06-17 2017-10-05 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CA2635603C (en) * 2005-11-30 2016-01-19 Endo Pharmaceuticals Inc. Treatment of xerostomia
EP2037941B8 (de) * 2006-05-30 2015-07-01 OraHealth Corporation Cobalamin-zusammensetzungen zur behandlung oder prävention von mucositis
US9707185B2 (en) * 2007-05-07 2017-07-18 Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College Water-soluble nanoparticles containing water-insoluble compounds
US20090149433A1 (en) 2007-11-13 2009-06-11 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
EP2393491B1 (de) 2009-02-03 2020-04-22 Microbion Corporation Bismutthiole als antiseptika für epithelgewebe, akute und chronische wunden, bakterielle biofilme und andere anwendungsgebiete
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
CN102458419A (zh) * 2009-06-10 2012-05-16 埃克塞拉医学有限责任公司 组合物用于治疗粘膜炎的用途
IT1397132B1 (it) * 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
US20110237563A1 (en) * 2010-03-23 2011-09-29 Dominique Costantini Fast dissolving drug delivery systems
US20120053130A1 (en) * 2010-08-30 2012-03-01 Bristol-Myers Squibb Company Composition for enhancing absorption of a drug and method
EP2658538A2 (de) * 2010-12-30 2013-11-06 M.D. Ziv Harish Zubereitungen zur topischen vorbeugung und/oder behandlung von allergischen symptomen aufgrund des oralen kontakts mit früchten und/oder gemüse
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
US10426761B2 (en) * 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
WO2012145307A1 (en) * 2011-04-19 2012-10-26 Brian Sokol Method of inhibiting harmful microorganisms and barrier-forming composition therefor
ES2375784B1 (es) * 2011-12-22 2013-01-24 Laboratorios Kin S.A. Gel de ácido tranexámico
ES2795291T3 (es) 2013-02-13 2020-11-23 Procter & Gamble Medicamento con sabor a anís
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
EP2968651B1 (de) * 2013-03-15 2020-10-21 Cook Medical Technologies LLC Medizinische haftprodukte und verfahren zur behandlung von gastrointestinalen läsionen
US9433644B2 (en) 2013-07-25 2016-09-06 Rutgilli Pharmaceuticals, Llc Formulations and methods for treating oral inflammation, injury, or pain
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
US11103546B2 (en) 2014-01-29 2021-08-31 Vita Ice Therapeutics Llc Edible oil compositions to treat oral complications and methods of using same
WO2015126841A1 (en) 2014-02-18 2015-08-27 Plasmatech Biopharmaceuticals, Inc. Nutritional and therapeutic mucoadhesive formulations
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
EP3213760A4 (de) * 2014-10-27 2018-06-20 FBM Indústria Farmacêutica Ltda. Lösliche, stabile, entzündungshemmende, proliferative, schützende und mukoadhäsive pharmazeutische zusammensetzungen, verwendung davon zur behandlung von mukositis und verfahren zur herstellung davon, pharmazeutische basiszusammensetzung zur herstellung der pharmazeutischen zusammensetzungen und verfahren zur herstellung davon
US10888620B2 (en) 2016-11-28 2021-01-12 Johnson & Johnson Consumer Inc. Liquid compositions for treating cough or cold symptoms
US11413240B2 (en) * 2016-12-29 2022-08-16 Board Of Regents, The University Of Texas System Methylene blue solution for the treatment of oral lesions
FR3063226B1 (fr) * 2017-02-28 2020-05-08 Unither Pharmaceuticals Formulation pharmaceutique pour l'administration par voie bucco-gingivale de paracetamol
WO2019067680A1 (en) 2017-09-27 2019-04-04 Cook Medical Technologies Llc CROSSLINKING SUBMUCOSAL INJECTION SYSTEM
WO2020028558A1 (en) 2018-07-31 2020-02-06 Microbion Corporation Bismuth-thiol compositions and methods of use
AU2019312592B2 (en) 2018-07-31 2025-06-26 Microbion Corporation Bismuth-thiol compositions and methods for treating wounds
FI3870226T3 (fi) 2018-10-24 2023-09-15 Ferring Bv Mukoadhesiivisia kortikosteroidien farmaseuttisia koostumuksia
US12083209B2 (en) 2020-02-18 2024-09-10 Sunstar Americas, Inc. Oral care composition

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
EP0163696B1 (de) * 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Verwendung eines bioadhesives
US4738842A (en) * 1986-01-17 1988-04-19 Riker Laboratories Topical antiinflammatory compositions
US4851393A (en) * 1986-07-28 1989-07-25 Massachusetts Institute Of Technology Method for utilizing an exocellular polysaccharide isolated from zoogloea ramigera
US5081158A (en) * 1988-05-02 1992-01-14 Zila Pharmaceuticals, Inc. Compositions and in situ methods for forming films on body tissue
MC2204A1 (fr) * 1989-10-31 1992-11-26 Columbia Lab Inc Composition et methode d'humidification de tissus
DE69014081T2 (de) * 1989-10-31 1995-03-30 Columbia Laboratories, Inc., Miami, Fla. Mittel zur Feuchthaltung vaginalen Gewebes.
US6017521A (en) * 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
US5403578A (en) * 1994-02-08 1995-04-04 Gordon; Norman Stable tooth and gum dentifrice with microencapsulation and method for making same
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW438601B (en) 1994-05-18 2001-06-07 Janssen Pharmaceutica Nv New mucoadhesive emulsion compositions and a process for the preparation thereof
AU3726395A (en) * 1994-09-27 1996-04-19 Virotex Corporation Improved topical carriers for mucosal applications
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US20030098438A1 (en) * 1998-06-29 2003-05-29 Haslin Leonard Arthur Environmentally friendly compositions having antiicing, deicing or graffiti prevention properties
IT1277663B1 (it) 1995-09-28 1997-11-11 Crinos Industria Farmaco Sospensioni acquose stabili di mesalazina per uso topico
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
GB9610862D0 (en) * 1996-05-23 1996-07-31 Evans Brian K Pharmaceutical products
SE9602644D0 (sv) 1996-07-04 1996-07-04 Astra Ab New use
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US5900230A (en) * 1997-08-18 1999-05-04 Squigle, Inc. Dental products to treat and prevent periodontal disease
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
GB9812426D0 (en) 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US20020009478A1 (en) * 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
WO2000050078A1 (en) * 1999-02-26 2000-08-31 Chiron Corporation Use of bioadhesives and adjuvants for the mucosal delivery of antigens
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
BR0109162A (pt) * 2000-03-14 2005-01-11 Alcon Inc Viscoelásticos para uso na cirurgia do ouvido médio
IT1318649B1 (it) 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
US20020103219A1 (en) * 2000-10-05 2002-08-01 Jeremy Jacob Stable viscous liquid formulations of amlexanox for the prevention and treatment of mucosal diseases and disorders
US20030060447A1 (en) * 2002-04-24 2003-03-27 Mutlu Karakelle Non-aspirating transitional viscoelastics for use in surgery
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders

Also Published As

Publication number Publication date
DK1997478T3 (da) 2013-12-09
EP1997478A3 (de) 2008-12-10
ES2314049T3 (es) 2009-03-16
CA2441352A1 (en) 2002-08-22
EP1997478B1 (de) 2013-09-04
HK1126134A1 (en) 2009-08-28
CA2441352C (en) 2010-05-25
PT1363600E (pt) 2008-12-22
US20020168334A1 (en) 2002-11-14
DE60229109D1 (de) 2008-11-13
CY1108678T1 (el) 2014-04-09
EP1363600A1 (de) 2003-11-26
WO2002064113A1 (en) 2002-08-22
PT1997478E (pt) 2013-12-10
EP1363600B1 (de) 2008-10-01
ES2437846T3 (es) 2014-01-14
DK1363600T3 (da) 2009-01-26
EP1997478A2 (de) 2008-12-03
NZ549469A (en) 2009-02-28
US7547433B2 (en) 2009-06-16

Similar Documents

Publication Publication Date Title
ATE409458T1 (de) Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
ATE504579T1 (de) Antivirale mittel
NO20060424L (no) 5-heteroringbaserte P38 kinaseinhibitorer
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
ATE318601T1 (de) Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
BR0112756A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto
NO20034612L (no) 3,4-di-substituerte syklobuten-1,2-dioner, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for tilvirkning av medikamenter for behandling av kjemokinformidlede sykdommer
EA200400689A1 (ru) Фармацевтические и косметические композиции, содержащие ароматические альдегиды, содержащие оксигруппу
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
DE60205455D1 (de) Naphthyridinderivate
DK1315506T3 (da) Phospholipidderivater af valproinsyre og blandinger deraf
DK1057828T3 (da) Orale trovafloxacin-suspensioner
AR036357A1 (es) Composicion de gel endoparasiticida, un metodo para su preparacion y el uso de dicha composición para la manufactura de un medicamento.
BR0206549A (pt) Uso de flumazenil na produção de uma droga para o tratamento de dependência de álcool
DE60326069D1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
DE602006009556D1 (de) Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
EP4079281A4 (de) Entzündungshemmende flüssige zusammensetzung zum abdecken der mundschleimhaut und arzneimittel zur vorbeugung und/oder behandlung von stomatitis unter anwendung derselben
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
SE0102639D0 (sv) Novel compounds
SE0203817D0 (sv) New composition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1363600

Country of ref document: EP